Alan Davis

Alan Davis has an extensive work experience spanning over several companies. Alan began their career as Vice-President of Medical & Scientific Affairs at Nycomed Pharma in 2007. Alan later joined Nycomed Canada as the Vice-President of Medical & Scientific Affairs. In 2009, they founded Bescot Healthcare Canada Inc, where they served as the Chief Scientific Officer & Co-Owner until 2022. During this time, they also worked as the Chief Executive Officer at Abbinnett Consulting from 2019 onwards. In 2014, they took up roles as the President & Co-Owner at Bescot Healthcare International Ltd and as the Chief Scientific Officer & Director at BESCOT HEALTHCARE UK LIMITED. Alan also became an Associate member at the Royal Society of Medicine. In 2020, they became a Strategic Advisor & Director at Ellerca Health Corp. Additionally, they served as the Chief Executive Officer at Acor Diagnostics until 2022. Most recently, they joined FEND New Zealand & FEND Australia as the Chief Scientific Officer & Co-owner in 2022.

Alan Davis completed their education as follows:

From 1973 to 1976, they attended The University of Manchester, where they obtained a Bachelor of Science (BSc) with Joint Honors in Pharmacology and Physiology.

From 1976 to 1979, they pursued a Ph.D. in Neuropharmacology from the University of Southampton.

In 2000, they enrolled in an Executive Development program at Queen's University.

Alan Davis also holds an additional certification in ISO 13485:2003 Lead Auditor from BSI, as well as a certification from the Royal Society of Medicine. No specific dates of obtaining these certifications are provided.

Furthermore, it is mentioned that Alan Davis pursued studies in Strategic & Entrepreneurial Studies at York University, but no specific dates or degree information are provided for this program.